Vaccines against typhoid fever

被引:118
作者
Guzman, Carlos A.
Borsutzky, Stefan
Griot-Wenk, Monika
Metcalfe, Ian C.
Pearman, Jon
Collioud, Andre
Favre, Didier
Dietrich, Guido
机构
[1] Berna Biotech Ltd, CH-3018 Bern, Switzerland
[2] GBF, German Res Ctr Biotechnol, Div Microbiol, Vaccine Res Grp, Braunschweig, Germany
关键词
typhoid fever; vaccine; oral administration; Ty21a; Vi-antigen;
D O I
10.1016/j.vaccine.2005.07.111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because of high infectivity and significant disease burden, typhoid fever constitutes a major global health problem. Implementation of adequate food handling practices and establishment of safe water supplies-are the cornerstone for the development of an effective prevention program. However, vaccination against typhoid fever remains an essential tool for the effective management of this disease. Currently, there are two well tolerated and effective licensed vaccines. One is based on defined subunit virulence (Vi) polysaccharide antigen and can be administered either intramuscularly or subcutaneously and the other is based on the use of live attenuated bacteria for oral administration. The advantages and disadvantages of the various approaches taken in the development of a vaccine against typhoid fever are discussed, along with the potential for future vaccine candidates. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3804 / 3811
页数:8
相关论文
共 68 条
  • [1] PREVENTION OF TYPHOID-FEVER IN NEPAL WITH THE VI CAPSULAR POLYSACCHARIDE OF SALMONELLA-TYPHI - A PRELIMINARY-REPORT
    ACHARYA, IL
    LOWE, CU
    THAPA, R
    GURUBACHARYA, VL
    SHRESTHA, MB
    CADOZ, M
    SCHULZ, D
    ARMAND, J
    BRYLA, DA
    TROLLFORS, B
    CRAMTON, T
    SCHNEERSON, R
    ROBBINS, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (18) : 1101 - 1104
  • [2] Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States -: Antimicrobial resistance on the rise
    Ackers, ML
    Puhr, ND
    Tauxe, RV
    Mintz, ED
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20): : 2668 - 2673
  • [3] *ADV COMM IMM PRAC, 1994, MMWR, V43
  • [4] [Anonymous], VACCINES
  • [5] Urgent need for effective vaccine against Salmonella paratyphi A, B and C
    Arya, SC
    Sharma, KB
    [J]. VACCINE, 1995, 13 (17) : 1727 - 1728
  • [6] Ashcroft M T, 1967, Lancet, V2, P1056
  • [7] CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED + ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES
    ASHCROFT, MT
    RITCHIE, JM
    NICHOLSON, CC
    [J]. AMERICAN JOURNAL OF HYGIENE, 1964, 79 (02): : 196 - +
  • [8] BHASKARAM P, 1990, INDIAN J MED RES-A, V91, P115
  • [9] BLACK R, 1982, DEV BIOLOGICALS, V53, P9
  • [10] EFFICACY OF ONE OR 2 DOSES OF TY21A SALMONELLA-TYPHI VACCINE IN ENTERIC-COATED CAPSULES IN A CONTROLLED FIELD TRIAL
    BLACK, RE
    LEVINE, MM
    FERRECCIO, C
    CLEMENTS, ML
    LANATA, C
    ROONEY, J
    GERMANIER, R
    [J]. VACCINE, 1990, 8 (01) : 81 - 84